Group L (n = 25) | Group R (n = 25) | P-value | |
---|---|---|---|
Age (y) | 40 ± 13 | 38 ± 13 | 0.553 |
Male sex | 11 (44%) | 9 (36%) | 0.564 |
Height (cm) | 169 ± 8 | 166 ± 8 | 0.187 |
Body weight (kg) | 64.4 ± 13.4 | 67.8 ± 14.2 | 0.392 |
Body mass index (kg/m2) | 22.6 (20.2, 27.3) | 22.5 (19.8, 26.6) | 0.684 |
ASA classification | 0.544 | ||
I | 16 (64%) | 18 (72%) | |
II | 9 (36%) | 7 (28%) | |
Laboratory tests | |||
Hemoglobin (g/L) | 141.4 ± 12.0 | 139.9 ± 12.9 | 0.676 |
Platelet (IU/L) | 256 ± 56 | 269 ± 54 | 0.818 |
Prothrombin time (s) | 11.6 (11.2, 12.2) | 11.4 (11.0, 11.8) | 0.232 |
Activated partial thromboplastin time (s) | 29.3 (28.2, 31.7) | 29.6 (27.6, 30.8) | 0.676 |
Airway evaluation | |||
Thyromental distance (cm) | 8.0 ± 0.8 | 7.7 ± 0.7 | 0.203 |
Inter-incisor gap (cm) | 4.5 ± 0.5 | 4.2 ± 0.6 | 0.055 |
Modified Mallampati classification | 0.225 | ||
I | 19 (76%) | 15 (60%) | |
II | 6 (24%) | 10 (40%) |